Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
08 Março 2024 - 9:00AM
PR Newswire (Canada)
MISSISSAUGA, ON, March 8,
2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH)
(OTCQX: CPHRF) ("Cipher" or the "Company") today
announced that it will release its financial results for the fourth
quarter and full year of 2023 after the market close on
Thursday, March 14, 2024. The Company
will also hold a conference call on Friday,
March 15 at 8:30 ET to discuss
the results and corporate developments.
CONFERENCE CALL DETAILS
DATE:
|
March 15,
2024
|
TIME:
|
8:30AM
|
DIAL-IN NUMBER:
|
416-764-8650 or
888-664-6383
|
REPLAY:
|
416-764-8677 or
888-390-0541 Code: 128854#
|
|
Expires: March 22,
2024
|
WEBCAST:
|
https://app.webinar.net/YqROVOGVJeP
|
About Cipher Pharmaceuticals
Inc.
Cipher Pharmaceuticals (TSX: CPH, OTCQX: CPHRF) is a specialty
pharmaceutical company with a robust and diversified portfolio of
commercial and early to late-stage products. Cipher acquires
products that fulfill unmet medical needs, manages the required
clinical development and regulatory approval process, and currently
markets those products either directly in Canada or
indirectly through partners in Canada, the U.S.,
and South America. For more information,
visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
Copyright 2024 Canada NewsWire
Cipher Pharmaceuticals (TSX:CPH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Cipher Pharmaceuticals (TSX:CPH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024